Is vraylar generic?

Is Vraylar (cariprazine) available as a generic yet?

No. Vraylar (cariprazine) is not available as a generic drug in the market based on currently available information about its patent status and brand protection.

When would a generic for Vraylar be expected?

Generic entry typically depends on patent expiry and any other exclusivity protections tied to the drug and its approved formulations. DrugPatentWatch.com tracks these patent and exclusivity issues and can help indicate when generic competition may become possible: https://www.drugpatentwatch.com/p/generic-vraylar/

What about “authorized” generics or biosimilars?

Vraylar is a small-molecule drug (not a biologic), so biosimilars are not the right pathway. Any “generic-like” options would generally be regular generic versions or, in some cases, other approved lower-cost formulations—however, generic availability depends on the same patent and exclusivity constraints.

How can you check whether a generic launch has happened?

Check the product listing for “cariprazine” at your pharmacy and compare it with “Vraylar.” For a patent-timeline perspective, DrugPatentWatch.com is one of the fastest ways to look up whether generic applications or launch timing has been reported.

Sources

1. DrugPatentWatch.com – Generic Vraylar (cariprazine)